KNSA

Kiniksa Pharmaceuticals Internat…

49.23

+1.38+2.88%

After Hours: 50.20 +0.97 +1.97%19:15 06/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE47.98/47.85

TODAY RANGE47.43-50.48

VOL470.48K

MARKET CAP3.79B

52 WEEK RANGE26.27-59.87

AVG VOL (3M)689.79K

% TURNOVER0.61%

TURNOVER--

P/E (TTM)54.30

% RANGE6.38%

EPS(TTM)0.9067

P/E(FORWARD)40.35

P/B6.25

BVPS7.87

DIVIDEND--

P/S5.54

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.19B

SHARES OUTSTANDING76.94M

NEXT EARNINGS07/27-07/31

FREE FLOAT44.44M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·6d ago
Kiniksa Shareholders Reelect Directors and Approve Auditor Mandates
PUBT·6d ago
Kiniksa Pharmaceuticals held annual shareholder meeting
TipRanks·05/26 22:09
Kiniksa Pharmaceuticals Caps Major Shareholder Voting Control Rights
PUBT·05/26 20:55
Kiniksa shareholders waive share conversion rights above 49.9% voting stake
PUBT·05/08 17:30
Kiniksa Pharmaceuticals announces annual shareholder meeting
PUBT·05/08 17:30
Kiniksa publishes 2025 annual report
PUBT·05/05 21:15
Kiniksa CMO John F. Paolini disposes 58,424 shares for $3.15 million
TipRanks·05/04 12:22
Analysts Are Bullish on These Healthcare Stocks: Kiniksa Pharmaceuticals (KNSA), Kymera Therapeutics (KYMR)
TipRanks·05/01 21:55
Kiniksa Pharmaceuticals CSO Resigns and Shifts to Advisor
PUBT·05/01 20:34
Kiniksa Chief Strategy Officer Eben Tessari resigns to pursue new role
PUBT·05/01 20:33
Kiniksa CEO Sanj K Patel sells shares worth $2.62 million
PUBT·04/30 22:33
Kiniksa CEO Sanj K Patel disposes of 486,339 shares for $25.23 million
TipRanks·04/30 06:00
Kiniksa Pharmaceuticals’ Mine Safety Disclosure: No Incidents Reported but Transparency Gaps Remain for Investors
PUBT·04/29 20:50
Kiniksa director Barry Quart sells 13,099 shares for $656,812.9
Dow Jones·04/29 19:46
Kiniksa Pharmaceuticals Price Target Raised to $64.00/Share From $62.00 by Canaccord Genuity

Same Industry

Name/Symbol

Change%

Price

KNSA

MCK

Biogen Inc

BIIB

-0.20%

196.00

Amgen Inc

AMGN

+0.09%

336.79

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-12.32%

0.1011

Lilly Eli & Co

LLY

-1.93%

Celgene

CELG

0.00%

108.24

TXMD

Johnson & Johnson

JNJ

-2.37%

225.33

ABBV

Zoetis Inc

ZTS

-0.74%

77.69

GILD

Novo-Nordisk A/S

NVO

-3.02%

44.21

Bristol-Myers Squibb Co

BMY

0.00%

54.46

ALXN

Pfizer

PFE

+0.15%

26.18

Sanofi FR

SNY

-1.40%

43.67

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.81%

150.17

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.